QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
28 Agosto 2023 - 3:05PM
Business Wire
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a
global provider of innovative in vitro diagnostics technologies
designed for point-of-care settings, clinical labs and transfusion
medicine, announced today that members of its management team are
scheduled to participate in the Morgan Stanley 21st Annual Global
Healthcare Conference in New York on September 12, 2023.
Douglas Bryant, President and Chief Executive Officer, and
Joseph Busky, Chief Financial Officer, will participate in a
fireside chat scheduled for 2:55 p.m. ET / 11:55 a.m. PT.
Interested parties can access the live webcast and replay on the
“Events & Presentations” section of the “Investor Relations”
page of QuidelOrtho’s website at https://ir.quidelortho.com/.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in
vitro diagnostics, developing and manufacturing intelligent
solutions that transform data into understanding and action for
more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular
testing, clinical chemistry and transfusion medicine, bringing
fast, accurate and reliable diagnostics when and where they are
needed – from home to hospital, lab to clinic. So that patients,
clinicians and health officials can spot trends sooner, respond
quicker and chart the course ahead with accuracy and
confidence.
Building upon its 80-year legacy of groundbreaking innovation,
QuidelOrtho continues to partner with customers across the
healthcare continuum and around the globe to forge a new diagnostic
frontier. One where insights and solutions know no bounds,
expertise seamlessly connects and a more informed path is
illuminated for each of us.
QuidelOrtho is transforming the power of diagnostics into a
healthier future for all.
For more information, please visit www.quidelortho.com.
Source: QuidelOrtho Corporation
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230828329265/en/
Investor Contact: IR@QuidelOrtho.com
Media: media@Quidel.com
QuidelOrtho (NASDAQ:QDEL)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
QuidelOrtho (NASDAQ:QDEL)
Gráfica de Acción Histórica
De May 2023 a May 2024